Teva Pharmaceutical Industries Aktie

21,20 EUR +0,70 EUR +3,41 %

20.12.2024

FSE

22,17 USD +0,08 USD +0,36 %

nachbörslich20.12.2024

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Div. Rendite0,00%

WKN883035

ISINUS8816242098

SymbolTEVA

Teva Pharmaceutical Industries Aktien News

Sortieren:Datum Meistgelesen

15:51BenzingaTeva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

20.12.24GlobeNewswireTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

18.12.24BenzingaTeva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

WerbungTeva Pharmaceutical Industries-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

18.12.24GlobesTeva share price at 6-year high after trial results

18.12.24ZacksSNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

18.12.24ZacksStrength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength?

18.12.24BenzingaNukkleus, Micron, Teva Pharmaceutical, Quantum Computing, Tesla: Why These 5 Stocks Are On Investors' Radars Today

17.12.24GlobesTeva jumps sharply on bowel disease drug results

17.12.24BenzingaRCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday

17.12.24BenzingaWhy Are Teva And Sanofi Stocks Trading Higher On Tuesday?

17.12.24GlobeNewswireTeva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

11.12.24GlobeNewswireTeva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

09.12.24GlobesTeva divests from Japanese JV with Takeda

06.12.24GlobeNewswireTeva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

04.12.24GlobeNewswireTeva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

28.11.24ZacksTEVA Stock Down 10% in a Month: Should You Buy the Dip?

26.11.24GlobeNewswireTeva to Present at the 7th Annual Evercore ISI HealthCONx Conference

19.11.24GlobesDespite price cuts, Tesla loses its shine in Israel

08.11.24GlobeNewswireTeva to Present at the Jefferies London Healthcare Conference

08.11.24ZacksAre Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?

07.11.24ZacksTEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase

06.11.24MotleyFoolTeva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

06.11.24BenzingaGeneric Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast

06.11.24ZacksTeva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say

06.11.24GlobesTeva reports seventh straight quarter of growth

04.11.24ZacksTeva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?

01.11.24GlobeNewswireTeva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

01.11.24GlobeNewswireTeva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanza

01.11.24ZacksCountdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

31.10.24Financial TimesEU fines world’s largest generic drugmaker Teva for hindering competition

31.10.24GlobeNewswireTeva Statement on European Commission Decision; Company to Appeal

30.10.24GlobesTeva leapfrogs Check Point as Israel's most valuable company

25.10.24ZacksWall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know

23.10.24BenzingaA Closer Look at 4 Analyst Recommendations For Teva Pharmaceutical Indus

23.10.24ZacksShould Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?

23.10.24ZacksAre Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?

22.10.24GlobeNewswireAlvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (us

18.10.24ZacksFOLD Stock Rises on Settling Galafold Patent Dispute With Teva

17.10.24BenzingaAmicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug

14.10.24GlobesTeva shareholder sues after $450m US settlement

Teva Pharmaceutical Industries News

Teva Pharmaceutical Industries News: auf dieser Seite finden Sie alle Teva Pharmaceutical Industries News und Nachrichten zur Teva Pharmaceutical Industries Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Teva Pharmaceutical Industries News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Teva Pharmaceutical Industries News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.